vs
Side-by-side financial comparison of Agilent Technologies (A) and Cboe Global Markets (CBOE). Click either name above to swap in a different company.
Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.3B, roughly 1.4× Cboe Global Markets). Cboe Global Markets runs the higher net margin — 30.3% vs 17.0%, a 13.3% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs 6.5%). Over the past eight quarters, Cboe Global Markets's revenue compounded faster (14.3% CAGR vs 6.9%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Cboe Global Markets, Inc. is an American financial exchange operator headquartered in Chicago. It owns and operates a portfolio of exchanges and trading venues across equities, options, futures, and digital assets.
A vs CBOE — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.3B |
| Net Profit | $305.0M | $385.7M |
| Gross Margin | 52.6% | 57.3% |
| Operating Margin | 19.6% | 39.7% |
| Net Margin | 17.0% | 30.3% |
| Revenue YoY | 7.0% | 6.5% |
| Net Profit YoY | -4.1% | 53.9% |
| EPS (diluted) | $1.07 | $3.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | $1.3B | ||
| Q4 25 | $1.9B | $1.2B | ||
| Q3 25 | $1.7B | $1.1B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.7B | $1.2B | ||
| Q4 24 | $1.7B | $1.1B | ||
| Q3 24 | $1.6B | $1.1B | ||
| Q2 24 | $1.6B | $974.0M |
| Q1 26 | $305.0M | $385.7M | ||
| Q4 25 | $434.0M | $313.5M | ||
| Q3 25 | $336.0M | $300.8M | ||
| Q2 25 | $215.0M | $235.1M | ||
| Q1 25 | $318.0M | $250.6M | ||
| Q4 24 | $351.0M | $196.5M | ||
| Q3 24 | $282.0M | $218.5M | ||
| Q2 24 | $308.0M | $140.4M |
| Q1 26 | 52.6% | 57.3% | ||
| Q4 25 | 53.2% | 55.7% | ||
| Q3 25 | 51.1% | 53.0% | ||
| Q2 25 | 51.9% | 50.0% | ||
| Q1 25 | 53.5% | 47.3% | ||
| Q4 24 | 53.9% | 47.4% | ||
| Q3 24 | 54.2% | 50.4% | ||
| Q2 24 | 54.4% | 52.8% |
| Q1 26 | 19.6% | 39.7% | ||
| Q4 25 | 23.8% | 33.5% | ||
| Q3 25 | 20.7% | 32.4% | ||
| Q2 25 | 18.0% | 28.9% | ||
| Q1 25 | 22.4% | 29.6% | ||
| Q4 24 | 24.0% | 27.0% | ||
| Q3 24 | 21.1% | 29.1% | ||
| Q2 24 | 23.1% | 21.6% |
| Q1 26 | 17.0% | 30.3% | ||
| Q4 25 | 23.3% | 26.0% | ||
| Q3 25 | 19.3% | 26.3% | ||
| Q2 25 | 12.9% | 20.0% | ||
| Q1 25 | 18.9% | 21.0% | ||
| Q4 24 | 20.6% | 17.7% | ||
| Q3 24 | 17.9% | 20.7% | ||
| Q2 24 | 19.6% | 14.4% |
| Q1 26 | $1.07 | $3.66 | ||
| Q4 25 | $1.53 | $2.97 | ||
| Q3 25 | $1.18 | $2.85 | ||
| Q2 25 | $0.75 | $2.23 | ||
| Q1 25 | $1.11 | $2.37 | ||
| Q4 24 | $1.23 | $1.85 | ||
| Q3 24 | $0.97 | $2.07 | ||
| Q2 24 | $1.05 | $1.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $2.1B |
| Total DebtLower is stronger | $3.0B | $1.4B |
| Stockholders' EquityBook value | $6.9B | $5.4B |
| Total Assets | $12.8B | $11.1B |
| Debt / EquityLower = less leverage | 0.44× | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | $2.1B | ||
| Q4 25 | $1.8B | $2.3B | ||
| Q3 25 | $1.5B | $1.5B | ||
| Q2 25 | $1.5B | $1.5B | ||
| Q1 25 | $1.5B | $1.2B | ||
| Q4 24 | $1.3B | $1.0B | ||
| Q3 24 | $1.8B | $763.2M | ||
| Q2 24 | $1.7B | $698.3M |
| Q1 26 | $3.0B | $1.4B | ||
| Q4 25 | $3.0B | $1.4B | ||
| Q3 25 | $3.4B | $1.4B | ||
| Q2 25 | $3.3B | $1.4B | ||
| Q1 25 | $3.3B | $1.4B | ||
| Q4 24 | $3.3B | $1.4B | ||
| Q3 24 | $2.1B | $1.4B | ||
| Q2 24 | $2.1B | $1.4B |
| Q1 26 | $6.9B | $5.4B | ||
| Q4 25 | $6.7B | $5.1B | ||
| Q3 25 | $6.4B | $4.9B | ||
| Q2 25 | $6.1B | $4.7B | ||
| Q1 25 | $6.0B | $4.5B | ||
| Q4 24 | $5.9B | $4.3B | ||
| Q3 24 | $5.9B | $4.2B | ||
| Q2 24 | $6.2B | $4.0B |
| Q1 26 | $12.8B | $11.1B | ||
| Q4 25 | $12.7B | $9.3B | ||
| Q3 25 | $12.2B | $9.1B | ||
| Q2 25 | $12.2B | $9.0B | ||
| Q1 25 | $11.9B | $8.7B | ||
| Q4 24 | $11.8B | $7.8B | ||
| Q3 24 | $11.0B | $8.7B | ||
| Q2 24 | $10.9B | $9.3B |
| Q1 26 | 0.44× | 0.27× | ||
| Q4 25 | 0.45× | 0.28× | ||
| Q3 25 | 0.53× | 0.30× | ||
| Q2 25 | 0.55× | 0.31× | ||
| Q1 25 | 0.56× | 0.32× | ||
| Q4 24 | 0.57× | 0.34× | ||
| Q3 24 | 0.36× | 0.34× | ||
| Q2 24 | 0.34× | 0.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | — |
| Free Cash FlowOCF − Capex | $175.0M | — |
| FCF MarginFCF / Revenue | 9.7% | — |
| Capex IntensityCapex / Revenue | 5.2% | — |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $352.1M | ||
| Q3 25 | $362.0M | $153.9M | ||
| Q2 25 | $221.0M | $333.7M | ||
| Q1 25 | $431.0M | $912.9M | ||
| Q4 24 | $481.0M | $-710.4M | ||
| Q3 24 | $452.0M | $-578.5M | ||
| Q2 24 | $333.0M | $1.5B |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $332.1M | ||
| Q3 25 | $259.0M | $137.9M | ||
| Q2 25 | $107.0M | $313.4M | ||
| Q1 25 | $334.0M | $898.2M | ||
| Q4 24 | $388.0M | $-734.2M | ||
| Q3 24 | $360.0M | $-590.5M | ||
| Q2 24 | $230.0M | $1.5B |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 27.6% | ||
| Q3 25 | 14.9% | 12.1% | ||
| Q2 25 | 6.4% | 26.7% | ||
| Q1 25 | 19.9% | 75.2% | ||
| Q4 24 | 22.8% | -66.3% | ||
| Q3 24 | 22.8% | -55.9% | ||
| Q2 24 | 14.6% | 151.6% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 1.7% | ||
| Q3 25 | 5.9% | 1.4% | ||
| Q2 25 | 6.8% | 1.7% | ||
| Q1 25 | 5.8% | 1.2% | ||
| Q4 24 | 5.5% | 2.1% | ||
| Q3 24 | 5.8% | 1.1% | ||
| Q2 24 | 6.5% | 1.8% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 1.12× | ||
| Q3 25 | 1.08× | 0.51× | ||
| Q2 25 | 1.03× | 1.42× | ||
| Q1 25 | 1.36× | 3.64× | ||
| Q4 24 | 1.37× | -3.62× | ||
| Q3 24 | 1.60× | -2.65× | ||
| Q2 24 | 1.08× | 10.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
CBOE
| Derivatives markets | $609.3M | 48% |
| Cash and spot markets | $482.2M | 38% |
| Data Vantage | $181.3M | 14% |
